Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages
Authors:
Open Access
- 12 July 2021
- journal article
- research article
- Published by Springer Nature in Sleep and Breathing
- Vol. 26 (2) , 893-906
Abstract
Purpose: Intermittent hypoxia (IH), a hallmark of obstructive sleep apnea (OSA), compromises immune surveillance through the upregulation of programmed cell death-1 ligand (PD-L1). Tumor-released extracellular vesicles (EVs) have been reported to modulate immunosuppressive activities. We investigated whether or not EVs derived from intermittent hypoxic lung cancer cells can alter the expression of PD-L1 in macrophages. Methods: The expression of PD-L1+monocytes from 40 patients with newly diagnosed non-small-cell lung cancer (NSCLC) and with (n=21) or without (n=19) OSA were detected. Plasma EVs isolated from NSCLC patients with moderate–severe OSA (n=4) and without OSA (n=4) were co-cultured with macrophages. A549 cells were exposed to normoxia or IH (48 cycles of 5 min of 1% O2 hypoxia, followed by 5 min of normoxia). EVs were isolated from cell supernatant and were co-cultured with macrophages differentiated from THP-1. PD-L1 and hypoxia-inducible factor-1 α (HIF-1α) expressions were measured by flow cytometry, immunofluorescence, and Western blot analysis. Results: PD-L1+monocytes were elevated in NSCLC patients with OSA and increased with the severity of OSA and nocturnal desaturation. PD-L1+ macrophages were induced by EVs from NSCLC patients with OSA and positively correlated with HIF-1α expressions. EVs from IH-treated A549 can promote PD-L1 and HIF-1α expression in macrophages and the upregulation of PD-L1 expression was reversed by specific HIF-1α inhibitor. Conclusion: IH can enhance the function of EVs derived from lung cancer cells to aggravate immunosuppressive status in macrophages. HIF-1α may play an important role in this process.Keywords
Funding Information
- Science and Technology Planning Project of Guangdong Province (2017A070701014)
This publication has 41 references indexed in Scilit:
- Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large OncosomesSeminars in Cell & Developmental Biology, 2015
- High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical CancerCancer Immunology Research, 2015
- Targeting hypoxia at the forefront of anticancer immune responsesOncoImmunology, 2014
- The polymorphic and contradictory aspects of intermittent hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activationJournal of Experimental Medicine, 2014
- Sleep Apnea and 20-Year Follow-Up for All-Cause Mortality, Stroke, and Cancer Incidence and Mortality in the Busselton Health Study CohortJournal of Clinical Sleep Medicine, 2014
- Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated EventsJournal of Clinical Sleep Medicine, 2012
- Sleep-disordered Breathing and Cancer Mortality: Results from the Wisconsin Sleep Cohort StudyAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoeaEuropean Respiratory Journal, 2011